Dawn L. Hershman, MD, Herbert Irving Comprehensive Cancer Center at Columbia University
Advertisement
Articles by Dawn L. Hershman, MD, Herbert Irving Comprehensive Cancer Center at Columbia University
Advertisement
Latest Updated Articles
Rapid Readouts: Updated Results From KX-ORAX-001 StudyDecember 23rd 2020
Advertisement
Advertisement
Trending on OncLive
1
Intismeran Autogene Plus Pembrolizumab Meets RFS and DMFS End Points in Resected Stage IIB-IV Melanoma
2
ESMO Guidelines Express Update Recommends Daraxonrasib for RAS G12–Mutated Metastatic PDAC
3
mRNA Vaccines May Help Increase Long-Term Disease Control in PDAC
4
FDA Grants Fast Track Designation to PLN-101095 Plus Pembrolizumab in Solid Tumors
5